Although the high-risk group has a considerable proportion of resting memory CD4+ T cells, studies have shown that tumor cells can weaken T cell reactivity and antigen processing capacity, so that T cells cannot effectively control tumor growth (44). Here, CD4 is linked to neoplasm.